A Case of Neuroleptic Malignant Syndrome Requiring Intensive Care Follow-up: A New Perspective on Fever Diagnosis After the COVID-19 Outbreak

2020 
Neuroleptic malignant syndrome is rare in neurology practice It may occur due to the use of high doses of antipsychotics It requires intensive care follow-up due to its severe complications and has high mortality Fever, rigidity, confusion, and respiratory distress are important symptoms of the condition It is important to note that this disease should be considered in the differential diagnosis of patients with fever, especially after the coronavirus disease-2019 disease that emerged in 2019-2020, and whose fever does not decrease as an important symptom For these reasons, we think that the presentation of this phenomenon will be useful (English) [ABSTRACT FROM AUTHOR] Noroleptik malign sendrom noroloji pratiginde az rastlanilan, yuksek doz antipsikotiklerin kullanilmasi sonucu ortaya cikan ve fatal seyretme riskinin yuksek olmasi nedeniyle yogun bakim izlemi gerektiren bir tablodur Hastada ates, rijidite, konfuzyon, solunum sikintisi gorulebilecek onemli semptomlardir Ozellikle 2019-2020 yilinda ortaya cikan ve onemli bir belirtisi de dusmeyen ates yuksekligi olan koronavirus hastaligi-19 hastaligindan sonra ates yuksekligi ile basvuran, anamnezi uygun olan hastalarin ayirici tanisinda akilda bulundurulmasi gereken bir hastalik oldugu konusunda farkindaligin olmasi onemlidir Bu amaclardan yola cikarak bu olgunun sunumunun yararli olacagini dusunmekteyiz (Turkish) [ABSTRACT FROM AUTHOR] Copyright of Turkish Journal of Intensive Care is the property of Galenos Yayinevi Tic LTD STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission However, users may print, download, or email articles for individual use This abstract may be abridged No warranty is given about the accuracy of the copy Users should refer to the original published version of the material for the full abstract (Copyright applies to all Abstracts )
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []